Lung volume reduction surgery is an old operation that was recently revived
as a surgical treatment for patients with severe emphysema, a disease for
which there are few other therapeutic options. It appears that, by removing
some portion of the diseased lung tissue, the elastic recoil of the remain
ing tissue is improved, resulting in increased expiratory airflow and the r
espiratory muscles are allowed to operate at closer to their optimal force-
generating length, resulting in increased inspiratory force. Although a sig
nificant amount of experience has been gained with the procedure, and there
is now little doubt that a subgroup of patients benefit from the operation
when performed in centers equipped to care for this challenging patient co
hort, a Hide variety of questions remain to be answered. These areas of con
troversy include issues as far ranging as patient selection, surgical techn
ique, durability and extent of benefit, and remaining basic issues surround
ing the physiological mechanism of effect. The National Emphysema Treatment
Trial has been organized to address many of these outstanding questions. I
t is hoped that this trial will confirm early reports documenting the benef
its to be gained from the procedure and help guide application of the opera
tion in the future.